115 related articles for article (PubMed ID: 18071880)
1. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.
Lin CH; Wang SC; Ou TT; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 May; 28(3):207-13. PubMed ID: 18071880
[TBL] [Abstract][Full Text] [Related]
2. IkappaBalpha promoter polymorphisms in patients with Behçet's disease.
Hung YH; Wu CC; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Dis Markers; 2010; 28(1):55-62. PubMed ID: 20164548
[TBL] [Abstract][Full Text] [Related]
3. IkBα promoter polymorphisms in patients with ankylosing spondylitis.
Hung YH; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Rheumatol Int; 2009 Nov; 30(1):93-7. PubMed ID: 19363678
[TBL] [Abstract][Full Text] [Related]
4. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Balood M; Mesbah-Namin SA; Sanati MH; Zahednasab H; Sahraian MA; Ataei M
Mol Biol Rep; 2014 Feb; 41(2):613-6. PubMed ID: 24368589
[TBL] [Abstract][Full Text] [Related]
6. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Int J Immunogenet; 2007 Feb; 34(1):51-4. PubMed ID: 17284228
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan.
Wang SC; Chen YJ; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2006 Nov; 26(6):506-11. PubMed ID: 17024563
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians.
Zhai R; Zhou W; Gong MN; Thompson BT; Su L; Yu C; Kraft P; Christiani DC
Crit Care Med; 2007 Mar; 35(3):893-8. PubMed ID: 17235259
[TBL] [Abstract][Full Text] [Related]
9. The association of -627 interleukin-10 promoter polymorphism in Chinese patients with systemic lupus erythematosus.
Lin PW; Huang CM; Huang CC; Tsai CH; Tsai JJ; Chang CP; Tsai FJ
Clin Rheumatol; 2007 Mar; 26(3):298-301. PubMed ID: 16826368
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
11. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
[TBL] [Abstract][Full Text] [Related]
12. CCR5 promoter region polymorphisms in systemic lupus erythematosus.
Schauren JDS; de Oliveira AH; Consiglio CR; Monticielo OA; Xavier RM; Nunes NS; Ellwanger JH; Chies JAB
Int J Immunogenet; 2024 Feb; 51(1):20-31. PubMed ID: 37984413
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.
Li RN; Hung YH; Lin CH; Chen YH; Yen JH
J Clin Immunol; 2010 Sep; 30(5):676-80. PubMed ID: 20563630
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
16. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study.
Panda AK; Tripathy R; Das BK
Lupus; 2021 Feb; 30(2):219-227. PubMed ID: 33176568
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE.
Mohammadoo-Khorasani M; Salimi S; Tabatabai E; Sandoughi M; Zakeri Z; Farajian-Mashhadi F
Indian J Med Res; 2016 May; 143(5):591-6. PubMed ID: 27488002
[TBL] [Abstract][Full Text] [Related]
18. IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan.
Lin YJ; Wan L; Huang CM; Sheu JJ; Chen SY; Lin TH; Chen DY; Hsueh KC; Lai CC; Tsai FJ
Clin Exp Rheumatol; 2010; 28(3):318-24. PubMed ID: 20576226
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans.
Jeon JY; Nam JY; Kim HA; Park YB; Bae SC; Suh CH
Arthritis Res Ther; 2014 May; 16(3):R112. PubMed ID: 24886807
[TBL] [Abstract][Full Text] [Related]
20. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
